Marjorie G. Zauderer

Also affiliated with Memorial Sloan Kettering Cancer Center, New York Oncology Hematology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.296Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

Papers

Driven by 34 papers — median percentile 22. Top paper: “Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis”.

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.030

N/A

1.1DataRank · unranked

27 citations

Zachary Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y. Gelblum, Raja-Elie E. Abdulnour +23 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0407

N/A

0.954DataRank · unranked

578 citations

Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill +25 more

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1112960

N/A

0.901DataRank · unranked

30 citations

Jennie K. Choe, Erin McGee, Rebecca Y. Bellis, Jasmeen Saini, Srijita Banerjee +5 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0.840DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Molecular Characterization of Peritoneal Mesotheliomas

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.09.012

N/A

0.593DataRank · unranked

51 citations

Soo‐Ryum Yang, Jacklynn V. Egger, Gowtham Jayakumaran, Rowanne S Spencer, Jessica Lopardo +8 more

YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

Nature Medicine(2025)10.1038/s41591-025-04029-3

N/A

0.578DataRank · unranked

46 citations

David J. Kwiatkowski, Ibiayi Dagogo-Jack, Michael Offin, Marjorie G. Zauderer, Robert A. Kratzke +13 more

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study

The Lancet Digital Health(2021)10.1016/s2589-7500(21)00104-7

N/A

0.564DataRank · unranked

42 citations

Axel Martin, Jacklynn V. Egger, Hira Rizvi, Michael Offin, Andreas Rimner +7 more

Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.017

N/A

0.557DataRank · unranked

40 citations

Marjorie G. Zauderer, Charles M. Rudin, Siân Jones, Semanti Mukherjee, Kenneth Offit +7 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

Modern Pathology(2024)10.1016/j.modpat.2023.100420

N/A

0.442DataRank · unranked

18 citations

Jason C. Chang, Achim A. Jungbluth, Prasad S. Adusumilli, Francis M. Bodd, Denise Frosina +13 more

Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.2526

N/A

0.406DataRank · unranked

14 citations

Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg +15 more

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Modern Pathology(2023)10.1016/j.modpat.2022.100030

N/A

0.396DataRank · unranked

13 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations

Cancer Medicine(2023)10.1002/cam4.5598

N/A

0.360DataRank · unranked

10 citations

Susan Chimonas, Sham Mailankody, Michelle Kim, Nicholas Silva, Anuja Kriplani +9 more

Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.110057

N/A

0.360DataRank · unranked

10 citations

Michael Offin, Charles B. Simone, Zhigang Zhang, Annemarie F. Shepherd, Abraham J. Wu +10 more

A phase 2 study of defactinib (VS-6063) in patients with NF2 altered tumors: Results from NCI-match (EAY131) subprotocol U.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3087

N/A

0.330DataRank · unranked

8 citations

Opeyemi A. Jegede, Marjorie G. Zauderer, Edith P. Mitchell, James A. Zwiebel, Robert J. Gray +13 more

Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0085

N/A

0.312DataRank · unranked

7 citations

Gowtham Jayakumaran, Jamal Benhamida, Christopher A. Febres Aldana, Rachel Fanaroff, Jason C. Chang +7 more

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors

Annals of Surgical Oncology(2024)10.1245/s10434-024-16004-2

N/A

0.292DataRank · unranked

6 citations

Nicole Aguirre, Soo Ryum Yang, Jennifer L. Sauter, Georgios Karagkounis, Mostafa Mohamed +9 more

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100440

N/A

0.292DataRank · unranked

6 citations

Prasad S. Adusumilli, Michael Offin, Stephen B. Solomon, Etay Ziv, Sara A. Hayes +22 more

Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma

Modern Pathology(2025)10.1016/j.modpat.2025.100706

N/A

0.292DataRank · unranked

6 citations

Soo‐Ryum Yang, Kay See Tan, Prasad S. Adusumilli, Francis M. Bodd, Anita S. Bowman +10 more

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1591

N/A

0.292DataRank · unranked

6 citations

Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo +19 more

Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U

JCO Precision Oncology(2024)10.1200/po.24.00327

N/A

0.260DataRank · unranked

4 citations

Opeyemi A. Jegede, David M. Jackman, James A. Zwiebel, Robert J. Gray, Victoria Wang +17 more

The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas

Journal of Cancer Metastasis and Treatment(2023)10.20517/2394-4722.2022.140

N/A

0.104DataRank · unranked

1 citations

Bailey G. Fitzgerald, Marjorie G. Zauderer, Deborah B. Doroshow, Michael Offin

Safety and efficacy of percutaneous cryoablation for primary and metastatic pleural based tumors

European Journal of Radiology(2024)10.1016/j.ejrad.2024.111465

N/A

0.104DataRank · unranked

1 citations

Elena N. Petre, Michael Offin, Marjorie G. Zauderer, Ken Zhao, Vlasios S. Sotirchos +3 more

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma

Nature Communications(2021)10.1038/s41467-021-22142-y

N/A

0DataRank · unranked

5 citations

Marjorie G. Zauderer

Dual NF2-YAP/TAZ immunohistochemistry is a reliable marker for the detection of NF2 alterations in diffuse pleural mesothelioma

Research Square(2022)10.21203/rs.3.rs-1720495/v1

N/A

0DataRank · unranked

0 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting

Cancer Cytopathology(2023)10.1002/cncy.22705

N/A

0DataRank · unranked

5 citations

Abeer M. Salama, Marina K. Baine, Francis M. Bodd, Michael Offin, Natasha Rekhtman +5 more

Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma

Translational Lung Cancer Research(2023)10.21037/tlcr-23-46

N/A

0DataRank · unranked

1 citations

Prasad S. Adusumilli, Marjorie G. Zauderer, Kevin M. Branch

Multimodality Therapy in Patients With Primary Pericardial Mesothelioma

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.08.017

N/A

0DataRank · unranked

16 citations

Dilanka L De Silva, Jennifer L. Sauter, Jacklynn V. Egger, Ellen Yorke, Prasad S. Adusumilli +4 more

Consensus guideline for the management of peritoneal mesothelioma

Cancer(2025)10.1002/cncr.35868

N/A

0DataRank · unranked

2 citations

Sarah G. Wilkins, Varun Bansal, David Su, Jorge L. Gomez‐Mayorga, Kiran K. Turaga +11 more

ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma

Annals of Surgical Oncology(2025)10.1245/s10434-025-18200-0

Top 100%

0DataRank

Top 100%0 citations

Fady Baky, Judy Sarungbam, Joel Sheinfeld, Victor E. Reuter, Andrea Cercek +9 more

A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9079

N/A

0DataRank · unranked

1 citations

Marjorie G. Zauderer, Ellen Yorke, Charles B. Simone, Ritu R. Gill, Khinh Ranh Voong +6 more

Marjorie G. Zauderer

Indexed papers

Top data-sharing exemplar

Papers